Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation.

Cell Stem Cell
Maria Carolina FlorianHartmut Geiger

Abstract

The decline in hematopoietic function seen during aging involves a progressive reduction in the immune response and an increased incidence of myeloid malignancy, and has been linked to aging of hematopoietic stem cells (HSCs). The molecular mechanisms underlying HSC aging remain unclear. Here we demonstrate that elevated activity of the small RhoGTPase Cdc42 in aged HSCs is causally linked to HSC aging and correlates with a loss of polarity in aged HSCs. Pharmacological inhibition of Cdc42 activity functionally rejuvenates aged HSCs, increases the percentage of polarized cells in an aged HSC population, and restores the level and spatial distribution of histone H4 lysine 16 acetylation to a status similar to that seen in young HSCs. Our data therefore suggest a mechanistic role for Cdc42 activity in HSC biology and epigenetic regulation, and identify Cdc42 activity as a pharmacological target for ameliorating stem cell aging.

References

Sep 1, 1996·Nature Medicine·S J MorrisonI L Weissman
Nov 9, 2000·The Journal of Experimental Medicine·K SudoH Nakauchi
Mar 29, 2002·Nature Immunology·Hartmut Geiger, Gary Van Zant
Jan 30, 2004·Nature Immunology·Phyllis Jean Linton, Kenneth Dorshkind
Mar 17, 2004·Journal of Cell Science·Sandrine Etienne-Manneville
Mar 31, 2004·The American Journal of Medicine·Claudia BeghéWilliam B Ershler
Mar 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hartmut GeigerGary Van Zant
Jun 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Derrick J RossiIrving L Weissman
Jun 3, 2006·Blood·Zhenlan XingHartmut Geiger
Jul 1, 2006·Nature·Thomas A Rando
Aug 8, 2006·Nature Neuroscience·Silvia CappelloMagdalena Götz
Jan 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Lei WangYi Zheng
Aug 19, 2007·Oncogene·A VaqueroD Reinberg
Oct 6, 2007·Stem Cell Reviews·S M Chambers, M A Goodell
Feb 26, 2008·Cell·Derrick J RossiIrving L Weissman
Jun 19, 2008·Cellular Signalling·Soniya Sinha, Wannian Yang
Oct 24, 2008·Nature Reviews. Molecular Cell Biology·Sandra Iden, John G Collard
Feb 28, 2009·Aging Cell·Richard A KerberRichard M Cawthon
Jun 23, 2009·Trends in Immunology·Hartmut Geiger, K Lenhard Rudolph
Jul 28, 2009·Current Opinion in Immunology·Kenneth Dorshkind, Susan Swain
Mar 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Isabel BeermanDerrick J Rossi
Jul 20, 2010·Stem Cells·Maria Carolina Florian, Hartmut Geiger
Mar 29, 2011·Oncogene·E A Pollina, A Brunet
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Vaidehi KrishnanZhongjun Zhou
Nov 24, 2011·The Journal of Experimental Medicine·Brad DykstraGerald de Haan
Feb 23, 2012·The Journal of Clinical Investigation·Ryotaro SakamoriNan Gao

❮ Previous
Next ❯

Citations

Aug 8, 2014·Nature Medicine·Juhyun OhAmy J Wagers
Aug 8, 2014·Nature Medicine·Avital Mendelson, Paul S Frenette
Jun 18, 2014·The Journal of Clinical Investigation·Brian S Garrison, Derrick J Rossi
Jun 7, 2014·Current Opinion in Immunology·Hartmut GeigerReinhold Schirmbeck
Aug 7, 2014·International Journal of Hematology·Ayako Nakamura-Ishizu, Toshio Suda
Aug 2, 2014·International Journal of Hematology·Motohiko Oshima, Atsushi Iwama
Mar 5, 2013·The Journal of Clinical Investigation·Encarnacion Montecino-RodriguezKenneth Dorshkind
Apr 26, 2013·Current Opinion in Hematology·Hartmut Geiger, Yi Zheng
Oct 3, 2013·Biogerontology·Hadas Raveh-AmitAndras Dinnyes
Oct 5, 2013·The Journal of Clinical Investigation·Holly MartinReuben Kapur
Sep 4, 2013·International Journal of Hematology·Takafumi YokotaYuzuru Kanakura
Jun 19, 2015·Expert Opinion on Drug Discovery·Yuan Lin, Yi Zheng
Feb 26, 2016·Brain : a Journal of Neurology·Khalil S RawjiV Wee Yong
Nov 7, 2015·Biochimica Et Biophysica Acta·Sheng-Wei YangYuan-Hao Howard Hsu
Jan 7, 2016·Nature Medicine·Hartmut Geiger
Mar 2, 2016·Annals of the New York Academy of Sciences·Shiri Gur-CohenTsvee Lapidot
Mar 6, 2016·Current Opinion in Immunology·Mohammed Yassin, Sarah M Russell
Dec 22, 2015·Cell Reports·Bettina M MoehrleHartmut Geiger
Nov 20, 2015·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Mahshid HodjatMohammad Abdollahi
Nov 28, 2015·Trends in Immunology·Michael D DenkingerHartmut Geiger
Mar 19, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Massimiliano CadamuroMario Strazzabosco
Oct 15, 2013·Immunological Reviews·Ramesh C NayakJose A Cancelas
Mar 13, 2014·Annals of the New York Academy of Sciences·Christina SchreckRouzanna Istvánffy
Jun 12, 2013·Cell·Carlos López-OtínGuido Kroemer
Dec 19, 2015·Stem Cells International·Fizzah Aziz Choudry, Mattia Frontini
Apr 14, 2016·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Chris I Jones
May 23, 2014·Biochemical Society Transactions·M Carmen Ortells, William M Keyes
Mar 5, 2016·Blood·Christelle Vincent-FabertEstelle Duprez
Jun 6, 2015·Cell Stem Cell·Isabel Beerman, Derrick J Rossi
Nov 12, 2013·Experimental Gerontology·Gianluigi MazzoccoliManlio Vinciguerra
Jan 7, 2014·Cell Stem Cell·Yi Zheng, Hartmut Geiger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis